VIVUS, Inc.
(Other OTC/NBB : VVUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. -0.95%84.062.1%$220.68m
JAZZJazz Pharmaceuticals Plc -3.24%137.312.4%$157.47m
HZNPHorizon Therapeutics Plc -1.65%78.615.8%$149.95m
SAVACassava Sciences, Inc. -8.64%9.200.0%$148.70m
CORTCorcept Therapeutics, Inc. -2.61%17.525.5%$122.70m
VRXValeant Pharmaceuticals International, Inc. -3.99%16.5114.1%$97.15m
BHCBausch Health Cos., Inc. -3.99%16.510.0%$68.41m
AMRNAmarin Corp. Plc -3.00%4.051.5%$55.09m
MYOKMyoKardia, Inc. -8.65%124.751.8%$52.71m
ARGXargenx SE -2.82%242.710.0%$52.02m
SAGESAGE Therapeutics, Inc. -4.26%59.798.6%$44.46m
GWPHGW Pharmaceuticals Plc -0.25%99.936.2%$40.64m
AXSMAxsome Therapeutics, Inc. -2.74%79.411.9%$37.95m
MRNSMarinus Pharmaceuticals, Inc. -3.89%3.331.9%$37.19m
PRGOPerrigo Co. Plc -3.27%45.536.8%$34.73m

Company Profile

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm’s products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.